SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-301105
Filing Date
2022-12-08
Accepted
2022-12-08 16:58:03
Documents
19
Period of Report
2022-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d421073d8k.htm   iXBRL 8-K 32744
2 EX-4.1 d421073dex41.htm EX-4.1 626836
6 GRAPHIC g42107381.jpg GRAPHIC 7155
7 GRAPHIC g42107382.jpg GRAPHIC 9172
8 GRAPHIC g42107384.jpg GRAPHIC 10008
9 GRAPHIC g42107387.jpg GRAPHIC 11645
10 GRAPHIC g421073g23o34.jpg GRAPHIC 7593
11 GRAPHIC g421073g89y18.jpg GRAPHIC 9005
  Complete submission text file 0001193125-22-301105.txt   988720

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lnth-20221208.xsd EX-101.SCH 2854
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20221208_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20221208_pre.xml EX-101.PRE 10815
13 EXTRACTED XBRL INSTANCE DOCUMENT d421073d8k_htm.xml XML 3235
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 221453049
SIC: 2835 In Vitro & In Vivo Diagnostic Substances